Antibody Therapeutics for Life

Notices


No Title Written by Written date Inquire
22   Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the ``Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology`` of Tumor Course of Harvard Medical School and for networking on September 5-8th, 2017.   Admin   2019-01-14   655  
21   Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting at INCHEON BIOPLUS 2017 - GLOBAL PARTNERING on September 13th, 2017.   Admin   2019-01-14   675  
20   Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting with Novartis BD&L on September 15th, 2017.   Admin   2019-01-14   674  
19   Dr. Jin-San Yoo, CEO of PharmAbcine will present as invited speaker at NOVARTIS GLOBAL PARTNERING CONFERENCE on September 14th, 2017.   Admin   2019-01-14   673  
18   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present as panelist at KoNECT-KDDF GLOBAL CLINICAL DEVELOPMENT FORUM on August 17th, 2017.   Admin   2019-01-14   664  
17   Dr. Lawrence Cher at Olivia Newton-Johns Cancer Wellness & Research Center/Austin Hospital is invited to present the interim data of Tanibirumab phase IIa recurrent GBM trial at 2017 SNO (Society for Neuro Oncology) meeting in San Francisco on November 16   Admin   2019-01-14   3,542  
16   PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.   Admin   2019-01-14   13,154  
15   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present for ``Investor Relation`` at MIRAE ASSET DAEWOO SECURITIES Corporate Day on July 12th, 2017.   Admin   2019-01-14   657  
14   Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with Bio-Pod   Admin   2019-01-14   855  
13   Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm in Seoul on June 23, 2017.   Admin   2019-01-14   707